Memorial Sloan Kettering Cancer Center’s Illumina ILMN Stock Holding History

Memorial Sloan Kettering Cancer Center’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,360	Closed	-$1.16M	–	5
2023 Q2	$1.16M	Hold	6,360	–	–	3.66%	5
2023 Q1	$1.44M	Hold	6,360	–	–	4.41%	4
2022 Q4	$1.25M	Hold	6,360	–	–	4.13%	4
2022 Q3	$1.18M	Hold	6,360	–	–	4.01%	5
2022 Q2	$1.14M	Sell	6,360 -720	-10%	-$184K	3.77%	5
2022 Q1	$2.41M	Sell	7,080 -10,597	-60%	-$3.58M	2.79%	5
2021 Q4	$6.54M	Hold	17,677	–	–	4.11%	5
2021 Q3	$6.97M	Buy	+17,677	New	+$8.13M	4.35%	5

Other funds holding ILMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Memorial Sloan Kettering Cancer Center's ILMN Position: Q3 2023 in Review

Memorial Sloan Kettering Cancer Center sold out of Illumina (ILMN) in Q3 2023, closing a stake of 6,360 shares — an estimated $1.16M sold.

Memorial Sloan Kettering Cancer Center first reported a position in ILMN in Q3 2021 and held it in 8 quarters. The position peaked at $6.97M in Q3 2021. 819 funds tracked by Wall St. Rank hold ILMN as of Q3 2023.

Memorial Sloan Kettering Cancer Center reported no remaining Illumina position as of Q3 2023 after selling out during the quarter.
Memorial Sloan Kettering Cancer Center sold 6,360 Illumina shares in Q3 2023, an estimated $1.16M.
Memorial Sloan Kettering Cancer Center first reported a position in Illumina in Q3 2021 and held it in 8 quarters.
Memorial Sloan Kettering Cancer Center's Illumina position peaked at $6.97M in Q3 2021.
819 funds tracked by Wall St. Rank held Illumina as of Q3 2023.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q3 2023, filed 14 Nov 2023.